FWBIFirst Wave BioPharma, Inc.

Nasdaq firstwavebio.com


$ 2.91 $ 0.08 (2.83 %)    

Thursday, 16-May-2024 10:04:43 EDT
QQQ $ 453.62 $ 0.15 (0.03 %)
DIA $ 400.50 $ 0.76 (0.19 %)
SPY $ 530.78 $ 0.79 (0.15 %)
TLT $ 92.36 $ -0.03 (-0.03 %)
GLD $ 219.79 $ -0.22 (-0.1 %)
$ 2.83
$ 2.84
$ 0.00 x 0
$ 2.86 x 100
$ 2.84 - $ 2.91
$ 2.33 - $ 60.00
44,733
na
7M
$ 1.07
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-14-2024 03-31-2024 10-Q
2 03-29-2024 12-31-2023 10-K
3 11-13-2023 09-30-2023 10-Q
4 08-14-2023 06-30-2023 10-Q
5 05-12-2023 03-31-2023 10-Q
6 03-20-2023 12-31-2022 10-K
7 11-14-2022 09-30-2022 10-Q
8 08-15-2022 06-30-2022 10-Q
9 05-23-2022 03-31-2022 10-Q
10 03-31-2022 12-31-2021 10-K
11 11-15-2021 09-30-2021 10-Q
12 08-16-2021 06-30-2021 10-Q
13 05-24-2021 03-31-2021 10-Q
14 03-31-2021 12-31-2020 10-K
15 11-16-2020 09-30-2020 10-Q
16 08-14-2020 06-30-2020 10-Q
17 05-15-2020 03-31-2020 10-Q
18 03-30-2020 12-31-2019 10-K
19 11-14-2019 09-30-2019 10-Q
20 08-13-2019 06-30-2019 10-Q
21 05-15-2019 03-31-2019 10-Q
22 04-01-2019 12-31-2018 10-K
23 11-09-2018 09-30-2018 10-Q
24 08-13-2018 06-30-2018 10-Q
25 05-14-2018 03-31-2018 10-Q
26 03-16-2018 12-31-2017 10-K
27 11-13-2017 09-30-2017 10-Q
28 08-14-2017 06-30-2017 10-Q
29 05-15-2017 03-31-2017 10-Q
30 03-31-2017 12-31-2016 10-K
31 11-25-2016 09-30-2016 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

 Entero Therapeutics, Inc. (formerly First Wave BioPharma, Inc.) (NASDAQ:ENTO) ("Entero" or the "Company"), a l...

 first-wave-biopharma-announces-11m-registered-direct-offering-of-366000-shares-of-common-stock-at-a-price-of-295share-priced-at-the-market

First Wave BioPharma, Inc., (NASDAQ:FWBI), ("First Wave BioPharma" or the "Company"), a clinical-stage biopharm...

 hc-wainwright--co-reinstates-neutral-on-first-wave-biopharma

HC Wainwright & Co. analyst Yi Chen reinstates First Wave BioPharma (NASDAQ:FWBI) with a Neutral.

 roth-mkm-maintains-buy-on-first-wave-biopharma-lowers-price-target-to-36

Roth MKM analyst Jonathan Aschoff maintains First Wave BioPharma (NASDAQ:FWBI) with a Buy and lowers the price target from $...

 why-limbach-holdings-shares-are-trading-lower-by-around-15-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of Limbach Holdings, Inc. (NASDAQ: LMB) fell sharply during Thursday’s session after the company reported fourth-quarte...

 first-wave-biopharma-completes-merger-deal-with-immunogenx-adding-phase-3-ready-candidate-for-celiac-disease

First Wave BioPharma acquires ImmunogenX, focusing on advancing GI pipeline. James Sapirstein remains Chairman & CEO, with ...

 first-wave-biopharma-inc-to-raise-4m-of-gross-proceeds-in-registered-direct-offering-of-525625-shares-of-common-stock-at-a-price-of-761-per-share

First Wave BioPharma, Inc., (NASDAQ:FWBI), ("First Wave BioPharma" or the "Company"), a clinical-stage biopharm...

 why-mobileye-global-shares-are-trading-lower-by-over-23-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of Mobileye Global Inc. (NASDAQ: MBLY) fell sharply during Thursday’s session after the company issued preliminary FY23...

 why-resources-connection-shares-are-trading-higher-by-over-6-here-are-20-stocks-moving-premarket

Shares of Resources Connection, Inc. (NASDAQ: RGP) rose sharply in pre-market trading following better-than-expected results f...

 whats-going-on-with-first-wave-biopharma-stock

First Wave BioPharma, Inc. (NASDAQ: FWBI) shares are trading higher Wednesday.  What To Know:

 roth-mkm-maintains-buy-on-first-wave-biopharma-adjusts-price-target-to-40

Roth MKM analyst Jonathan Aschoff maintains First Wave BioPharma (NASDAQ:FWBI) with a Buy, adjusts target to $40 from $11.

 why-sofi-technologies-shares-are-trading-lower-by-around-13-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of SoFi Technologies, Inc. (NASDAQ: SOFI) fell sharply during Wednesday’s session after Keefe, Bruyette & Woods dow...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION